Literature DB >> 8971859

The use of 3-methoxymethyl-16 beta, 17 beta-epiestriol-O-cyclic sulfone as the precursor in the synthesis of F-18 16 alpha-fluoroestradiol.

J L Lim1, L Zheng, M S Berridge, T J Tewson.   

Abstract

We have prepared 3-methoxymethyl-16 beta, 17 beta-epiestriol-O-cyclic sulfone (1c) and used it as a substrate for the production of F-18 16 alpha-fluoroestradiol, via nucleophilic fluorination with fluoride ion. The compound is straightforward to make from the commercially available epiestriol and is a stable crystalline compound that can be stored for at least a year at room temperature. Reaction with fluorine-18 fluoride provides excellent yields; typically > 90% incorporation of the fluoride is achieved. Partial purification of the labeled product may be accomplished at this stage. Hydrolysis of the methoxymethyl protecting group and ring-opened sulfate occurs rapidly in ethanolic acid solution. In the presence of water the hydrolysis requires more vigorous conditions and additional time but still proceeds to completion. Labeled fluoroestradiol is isolated at the end of a 1-2 h synthesis, depending on the hydrolysis method of 30-45% chemical (decay corrected) yield with respect to fluoride, with a specific activity > 1 Ci per micromole.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8971859     DOI: 10.1016/s0969-8051(96)00126-6

Source DB:  PubMed          Journal:  Nucl Med Biol        ISSN: 0969-8051            Impact factor:   2.408


  15 in total

1.  Small-animal PET of steroid hormone receptors predicts tumor response to endocrine therapy using a preclinical model of breast cancer.

Authors:  Amy M Fowler; Szeman Ruby Chan; Terry L Sharp; Nicole M Fettig; Dong Zhou; Carmen S Dence; Kathryn E Carlson; M Jeyakumar; John A Katzenellenbogen; Robert D Schreiber; Michael J Welch
Journal:  J Nucl Med       Date:  2012-06-05       Impact factor: 10.057

2.  A phase 2 study of 16α-[18F]-fluoro-17β-estradiol positron emission tomography (FES-PET) as a marker of hormone sensitivity in metastatic breast cancer (MBC).

Authors:  Lanell M Peterson; Brenda F Kurland; Erin K Schubert; Jeanne M Link; V K Gadi; Jennifer M Specht; Janet F Eary; Peggy Porter; Lalitha K Shankar; David A Mankoff; Hannah M Linden
Journal:  Mol Imaging Biol       Date:  2013-10-30       Impact factor: 3.488

3.  Factors influencing the uptake of 18F-fluoroestradiol in patients with estrogen receptor positive breast cancer.

Authors:  Lanell M Peterson; Brenda F Kurland; Jeanne M Link; Erin K Schubert; Svetlana Stekhova; Hannah M Linden; David A Mankoff
Journal:  Nucl Med Biol       Date:  2011-05-05       Impact factor: 2.408

4.  Longitudinal noninvasive imaging of progesterone receptor as a predictive biomarker of tumor responsiveness to estrogen deprivation therapy.

Authors:  Szeman Ruby Chan; Amy M Fowler; Julie A Allen; Dong Zhou; Carmen S Dence; Terry L Sharp; Nicole M Fettig; Farrokh Dehdashti; John A Katzenellenbogen
Journal:  Clin Cancer Res       Date:  2014-12-17       Impact factor: 12.531

5.  Improved Estrogen Receptor Assessment by PET Using the Novel Radiotracer 18F-4FMFES in Estrogen Receptor-Positive Breast Cancer Patients: An Ongoing Phase II Clinical Trial.

Authors:  Michel Paquette; Éric Lavallée; Serge Phoenix; René Ouellet; Helena Senta; Johan E van Lier; Brigitte Guérin; Roger Lecomte; Éric E Turcotte
Journal:  J Nucl Med       Date:  2017-08-10       Impact factor: 10.057

6.  Rapid synthesis of [18F]fluoroestradiol: remarkable advantage of microwaving over conventional heating.

Authors:  Jianfeng Shi; George Afari; Sibaprasad Bhattacharyya
Journal:  J Labelled Comp Radiopharm       Date:  2014-12-05       Impact factor: 1.921

7.  Pharmacodynamic imaging guides dosing of a selective estrogen receptor degrader.

Authors:  Pedram Heidari; Francis Deng; Shadi A Esfahani; Alicia K Leece; Timothy M Shoup; Neil Vasdev; Umar Mahmood
Journal:  Clin Cancer Res       Date:  2015-01-21       Impact factor: 12.531

Review 8.  Fluorinated tracers for imaging cancer with positron emission tomography.

Authors:  Olivier Couturier; André Luxen; Jean-François Chatal; Jean-Philippe Vuillez; Pierre Rigo; Roland Hustinx
Journal:  Eur J Nucl Med Mol Imaging       Date:  2004-07-06       Impact factor: 9.236

9.  Assessment of the novel estrogen receptor PET tracer 4-fluoro-11β-methoxy-16α-[(18)F]fluoroestradiol (4FMFES) by PET imaging in a breast cancer murine model.

Authors:  Michel Paquette; Serge Phoenix; René Ouellet; Réjean Langlois; Johan E van Lier; Eric E Turcotte; Francois Bénard; Roger Lecomte
Journal:  Mol Imaging Biol       Date:  2013-10       Impact factor: 3.488

10.  [18F]Fluorinated estradiol derivatives for oestrogen receptor imaging: impact of substituents, formulation and specific activity on the biodistribution in breast tumour-bearing mice.

Authors:  François Bénard; Naseem Ahmed; Jean-Mathieu Beauregard; Jacques Rousseau; Antonio Aliaga; Céléna Dubuc; Etienne Croteau; Johan E van Lier
Journal:  Eur J Nucl Med Mol Imaging       Date:  2008-03-13       Impact factor: 9.236

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.